2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Stomach Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Lung Neoplasms
3
Lymphatic Metastasis
2
Venous Thrombosis
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Stage IV or Unresectable Gastric Cancer
1
Rectal Neoplasms
1
Pilonidal Sinus
1
Pancreatic Neuroendocrine Tumors
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Pain
1
Neoplastic Cells, Circulating
1
Neoplasms
1
Malignant Neoplasm of Transverse Colon
1
Locally Advanced Gastric Cancer
1
Kidney Neoplasms
1
Endometrial Neoplasms
1
Colorectal Liver Metastasis
1
Choledochal Cyst
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Cisplatin
180
Radiotherapy
81
Paclitaxel
80
Brachytherapy
74
Carboplatin
72
pembrolizumab
63
Bevacizumab
40
Surveys and Questionnaires
29
Colposcopy
29
Radiation
28
Gemcitabine
28
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
27
Topotecan
26
Magnetic Resonance Spectroscopy
24
Blood Specimen Collection
23
human papillomavirus vaccine, L1 type 16, 18
22
Nivolumab
22
Drug Therapy
21
Papillomavirus Vaccines
20
atezolizumab
19
Platinum
19
Radiotherapy, Intensity-Modulated
18
Biopsy
18
Docetaxel
17
Taxes
16
Cyclophosphamide
16
Early Intervention, Educational
15
1,2-diaminocyclohexaneplatinum II citrate
15
Methods
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Cervical Neoplasms
×
Conversion to Open Surgery
×
Clear all
NCT04831580
2024-12-19
ROCC
GOG Foundation
Phase NA
Recruiting
840 enrolled